Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nia Health has developed award-winning digital health apps for atopic dermatitis ("Nia") and psoriasis ("Sorea"), which are the first of their kind to be approved worldwide. Their proprietary AI-driven platform enables automated lesion detection/classification, quantitative skin surface analysis, treatment progression tracking, objective disease severity measurement, automated clinical documentation, and research-grade image analysis. The company collaborates with insurance companies, pharmaceutical industry partners, clinics, patient associations—and provides daily support to thousands of patients. They generate real-world evidence from anonymized patient data to improve care outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nia Health.